1. Home
  2. CACI vs AXSM Comparison

CACI vs AXSM Comparison

Compare CACI & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$469.09

Market Cap

10.3B

Sector

Technology

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$240.80

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
AXSM
Founded
1962
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
12.0B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
CACI
AXSM
Price
$469.09
$240.80
Analyst Decision
Buy
Strong Buy
Analyst Count
12
17
Target Price
$689.50
$211.12
AVG Volume (30 Days)
265.1K
841.4K
Earning Date
04-22-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
38.56
EPS
17.11
N/A
Revenue
$4,467,860,000.00
N/A
Revenue This Year
$12.42
$57.24
Revenue Next Year
$10.00
$55.88
P/E Ratio
$27.26
N/A
Revenue Growth
2.60
N/A
52 Week Low
$434.70
$96.09
52 Week High
$683.50
$260.19

Technical Indicators

Market Signals
Indicator
CACI
AXSM
Relative Strength Index (RSI) 40.74 52.81
Support Level $434.70 $236.44
Resistance Level $511.94 $260.19
Average True Range (ATR) 19.23 8.55
MACD -2.89 -2.05
Stochastic Oscillator 31.53 17.73

Price Performance

Historical Comparison
CACI
AXSM

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: